Vedolizumab as Induction and Maintenance Therapy for Crohn's Disease

Autor: Sandborn, Wj, Feagan, Bg, Rutgeerts, P, Hanauer, S, Colombel, Jf, Sands, Be, Lukas, M, Fedorak, Rn, Lee, S, Bressler, B, Fox, I, Rosario, M, Sankoh, S, Xu, J, Stephens, K, Milch, C, Parikh, A, Bampton P, GEMINI 2 Study G. r. o. u. p., Borody, T, Chung, A, Debinski, H, Florin, T, Hetzel, D, Jakobovits, S, Lawrance, I, Leong, R, Macrae, F, Mitchell, B, Moore, G, Pavli, P, Samuel, D, Weltman, M, Haas, T, Reinisch, W, Vogel, W, Baert, F, De Maeyer, M, De Vos, M, Dewit, O, D'Haens, G, Louis, E, Muls, V, Van Assche, G, Krastev, Z, Nikolovska, D, Petrov, P, Petrov, A, Stoinov, S, Tchernev, K, Vasileva, G, Aumais, G, Axler, J, Bailey, R, Bernstein, C, Bitton, A, Bourdages, R, Cohen, A, Devroede, G, Dhalla, S, Feagan, B, Fedorak, R, Green, D, Greenberg, G, Jones, J, Larkai, E, Macintosh, D, Panaccione, R, Ponich, T, Singh, R, Sy, R, Wiesinger, H, Albin, A, Douda, L, Horny, I, Stehlik, J, Stuksa, J, Volfova, M, Vyhnalek, P, Zadorova, Z, Andersen, V, Bendtsen, F, Fallingborg, J, Rannem, T, Maelt, A, Margus, B, Salupere, R, Allez, M, Des Varennes SB, Desreumaux, P, Dupas, Jl, Grimaud, Jc, Hebuterne, X, Lerebours, E, Picon, L, Zerbib, F, Aldinger, V, Baumgart, D, Buening, C, Dollinger, M, Hoffmann, P, Howaldt, S, Klaus, J, Konturek, Jw, Krummenerl, T, Malfertheiner, P, Schmidt, W, Schreiber, S, Seidler, U, Stallmach, A, Stremmel, W, Zeitz, M, Mantzaris, G, Triantafyllou, K, Ng, C, Bene, L, Fazekas, I, Fejes, R, Gall, J, Horvat, G, Hunyady, B, Salamon, A, Toth, T, Tulassay, Z, Varga, E, Varga, M, Varga Szabo, L, Vincze, A, Oddsson, E, Örvar, K, Ahuja, V, Amarapurkar, D, Chandra, A, Koshy, A, Krishna, P, Ramakrishna, K, Reddy, N, Thorat, V, Patchett, S, Ryan, B, Ben Horin, S, Fishman, S, Lavy, A, Rachmilewitz, D, Ardizzone, S, Corazziari, E, Danese, S, Fries, Walter, Gasbarrini, A, Kohn, A, Sturniolo, Gc, Danilans, A, George, Am, Hilmi, In, Engels, Lg, Ponsioen, Cy, van der Woude CJ, Gearry, R, Haines, M, Schultz, M, Wallace, I, Wyeth, J, Florholmen, J, Jahnsen, J, Lygren, I, Röseth, A, Ciecko Michalska, I, Gonciarz, M, Horynski, M, Huk, J, Jamrozik Kruk, Z, Janke, A, Klupinska, G, Marecik, J, Paradowski, L, Rudzinski, J, Rydzewska, G, Han, Ds, Hong, Sp, Kim, Hj, Kim, Js, Kim, Ko, Kim, Yh, Yang, Sk, Gheorghe, Ls, Voiosu, Rm, Alexeeva, O, Baranovsky, A, Bunkova, E, Burnevich, E, Dolgikh, O, Grinevich, V, Lakhin, A, Tarabar, D, Ling, Kl, Bunganic, I, Cernok, S, Gregus, M, Coetzer, T, Grundling, H, Moola, Sa, Wright, Jp, Ziady, C, Bermejo, F, Calvet, X, Herrerias, Jm, Perez Calle JL, Perez Gisbert, J, Hertervig, E, Karlen, P, Michetti, P, Rogler, G, Seibold, F, Wu, Dc, Atug, O, Kurdas, Oo, Datsenko, O, Dorofyeyev, A, Dudar, L, Golovchenko, O, Klyarits'Ka, I, Skrypnyk, I, Hawthorne, Ab, Middleton, S, Abreu, M, Bala, N, Becker, S, Behm, B, Braun, R, Bukhari, M, Chen, S, Coates, A, Dar, S, Dassopoulos, T, De Villiers, W, Desautels, S, Desta, T, Dimitroff, J, Dryden, G, Duvall, A, Farraye, F, Fein, S, Liu, Bf, Gatof, D, Geenen, D, Ginsburg, P, Glombicki, A, Glover, S, Gordon, G, Grisolano, S, Hanson, J, Hardi, R, Hoffman, B, Isaacs, K, Kim, C, Koval, G, Lashner, B, Lawitz, E, Leman, B, Levine, J, Loftus, E, Mahadevan, U, Mannon, P, Marcet, J, Matsuyama, R, Matusow, G, Mccabe, R, Mirkin, K, Murphy, M, Mushahwar, A, Mutlu, E, Nagrani, M, Nguyen, D, Nichols, M, Nieves Ramirez, A, Oubre, B, Pace, S, Pandak, W, Perera, L, Quadri, A, Quallich, L, Rajapakse, R, Randall, C, Regueiro, M, Safdi, A, Sandborn, W, Sands, B, Saubermann, L, Scherl, E, Schwartz, D, Sedghi, S, Shafran, I, Shepard, R, Siegel, C, Stein, L, Tatum, H, Triebling, A, Vasudeva, R, Winston, B, Wolf, D, Younes, Z, Jewell, D, Mahon, J, Rothstein, R, Snydman, D, Massaro, J, Clifford, D, Berger, J, Major, E, Provenzale, J, Lev, M.

Publikováno v: Sandborn, W J, Feagan, B G, Rutgeerts, P, Hanauer, S, Colombel, J-F, Sands, B E, Lukas, M, Fedorak, R N, Lee, S, Bressler, B, Fox, I, Rosario, M, Sankoh, S, Xu, J, Stephens, K, Milch, C, Parikh, A, GEMINI 2 Study Group & Andersen, V 2013, ' Vedolizumab as induction and maintenance therapy for Crohn's disease ', The New England Journal of Medicine, vol. 369, no. 8, pp. 711-721 . https://doi.org/10.1056/NEJMoa1215739
New England Journal of Medicine, vol. 369, no. 8, pp. 711-721
New England Journal of Medicine, 369(8), 711-721. Massachussetts Medical Society

BACKGROUND: The efficacy of vedolizumab, an α4β7 integrin antibody, in Crohn's disease is unknown. METHODS: In an integrated study with separate induction and maintenance trials, we assessed intravenous vedolizumab therapy (300 mg) in adults with a

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cf374318adf97600bd8e435e89470ea7
https://doi.org/10.1056/nejmoa1215739

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

THU-263 - Tenofovir is more potent over entecavir in reducing the viral load in patients of hepatitis B reactivation presenting as Acute on Chronic Liver Failure (ACLF)-Results of multination study from APASL-ACLF Research Consortium (AARC)

Autor: Ahmad, J., Choudhury, A., Kumar, M., Al-Mahtab, M., Rahman, S., Ning, Q., Ma, K., Duan, Z., Chen, Y., Hu, J.H., Hu, J., Tan, S.-S., Hamid, S.S., Subhan, A., Jafri, W., Lesmana, L.A., Lesmana, R., Ghazinyan, H.L., Jia, J.-D., Lee, G.H., Lim, S.G., Taneja, S., Chawla, Y., Lau, G., Sahoo, M., Shukla, A., Deverbhavi, H., Yuen, M.-F., Abbas, Z., Amarapurkar, D., Karim, F., Treeprasertsuk, S., Dokmeci, A.K., Goel, A., Eapen, C., Payawal, D., Shah, S., Kalal, C., Kulkarni, A., Chaudhury, S., Paulson, I., Jain, P., Kumar, G., Sarin, S.K.

Publikováno v: In Journal of Hepatology April 2018 68 Supplement 1:S245-S245

THU-259 - Invasive fungal infections in Acute on chronic liver failure – An Asia Pacific experience from the AARC consortium

Autor: Taneja, S., Rathi, S., Dhiman, R.K., Duseja, A., Choudhury, A., Jain, P., Paulson, I., Deverbhavi, H., Tan, S.-S., Eapen, C., Goel, A., Shah, S., Kalal, C., Kadir Dokmeci, A., Shukla, A., Kim, D.J., Jia, J.-D., Amarapurkar, D., Lee, G.H., Lim, S.G., Padaki, N.R., Hamid, S.S., Jafri, W., Abbas, Z., Sarin, S.K.

Publikováno v: In Journal of Hepatology April 2018 68 Supplement 1:S243-S243

Portopulmonary hypertension in a case of non-cirrhotic portal fibrosis

Autor: Amonkar P, Gayathri, Deshpande R, Jaya, Amarapurkar D, Anjali, Karpate, Arti

Publikováno v: Indian journal of pathologymicrobiology. 50(4)

Portopulmonary hypertension (PPHT) is the unusual association of portal hypertension (HT) with pulmonary HT. We report a case of noncirrhotic portal fibrosis (NCPF) leading to PPHT which is exceedingly rare with only very few cases reported in the li

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::7b27910d56ffd73ac114b9e6dfb7110b
https://pubmed.ncbi.nlm.nih.gov/18306572